Dr. Sebastian Kobold

Sebastian Kobold, M.D. is a professor of experimental immunooncology, head of the immunopharmacology group, and deputy director of the division of clinical pharmacology at the University Hospital of Munich. He has received, among many other awards, the 2022 cancer research prize of the Berlin-Brandenburg Academy of Sciences. Focusing on tumor immunology, Dr. Kobold is especially interested in developing and testing novel strategies to treat cancer using the immune system. His goal is to translate his findings into clinical applications to improve therapies for cancer patients.